img

Global Orally Disintegrating Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Orally Disintegrating Drug Market Insights, Forecast to 2034

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Market Analysis and InsightsGlobal Orally Disintegrating Drug Market
Global Orally Disintegrating Drug market is expected to reach to US$ 2152 million in 2023, with a positive growth of %, compared with US$ 1957 million in 2024 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Orally Disintegrating Drug industry is evaluated to reach US$ 3709.6 million in 2034. The CAGR will be 9.5% during 2023 to 2034.
The orally disintegrating drug market is being driven by several factors. One of the primary drivers is the growing demand for convenient and patient-friendly medication delivery methods. Orally disintegrating drugs offer an advantage over traditional oral tablets as they quickly dissolve in the mouth without the need for water, making them easier to administer, particularly for individuals with swallowing difficulties, pediatric patients, and the elderly. Additionally, the increasing prevalence of chronic diseases and the need for efficient and immediate drug absorption have fueled the demand for orally disintegrating drugs. Furthermore, advancements in formulation technologies and taste-masking techniques have improved the palatability of these drugs, enhancing patient compliance. Overall, the demand for orally disintegrating drugs is driven by the need for convenience, improved patient experience, and enhanced drug delivery options in the pharmaceutical market.
Report Covers
This report presents an overview of global Orally Disintegrating Drug market from 2018 to 2034, aiming to help readers to get a comprehensive understanding of global Orally Disintegrating Drug market with multiple angles. Items like regional revenue from 2018 to 2034 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2034 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Johnson and Johnson
GSK
Otsuka
Vartris
Teva
Pfizer
Eli Lilly and Company
Merck
Eisai
AstraZeneca
Bristol-Myers Squibb
Conquer
Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other

Segment by Application


CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2034
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2034 globally
Chapter 5Product revenue analysis by application from 2018 to 2034 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2034 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2034
Chapter 7Product revenue analysis by type and application from 2018 to 2034 in Europe. Product revenue analysis of each country in Europe from 2018 to 2034
Chapter 8Product revenue analysis by type and application from 2018 to 2034 in China. Product revenue analysis of China from 2018 to 2034
Chapter 9Product revenue analysis by type and application from 2018 to 2034 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2034
Chapter 10Product revenue analysis by type and application from 2018 to 2034 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2034.
Chapter 11Companies’ outline, covering company’s basic information, major business, Orally Disintegrating Drug introduction, etc. Orally Disintegrating Drug Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12Mr Accuracy reports’s Conclusions of Orally Disintegrating Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orally Disintegrating Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Anti-Psychotics Drug
1.2.3 Anti-Epileptics Drug
1.2.4 Other
1.3 Market by Application
1.3.1 Global Orally Disintegrating Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 CNS Diseases
1.3.3 Gastrointestinal Diseases
1.3.4 CVS Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Orally Disintegrating Drug Market Perspective (2018-2034)
2.2 Global Orally Disintegrating Drug Growth Trends by Region
2.2.1 Orally Disintegrating Drug Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Orally Disintegrating Drug Historic Market Size by Region (2018-2023)
2.2.3 Orally Disintegrating Drug Forecasted Market Size by Region (2024-2034)
2.3 Orally Disintegrating Drug Market Dynamics
2.3.1 Orally Disintegrating Drug Industry Trends
2.3.2 Orally Disintegrating Drug Market Drivers
2.3.3 Orally Disintegrating Drug Market Challenges
2.3.4 Orally Disintegrating Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Orally Disintegrating Drug by Players
3.1.1 Global Orally Disintegrating Drug Revenue by Players (2018-2023)
3.1.2 Global Orally Disintegrating Drug Revenue Market Share by Players (2018-2023)
3.2 Global Orally Disintegrating Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Orally Disintegrating Drug, Ranking by Revenue, 2021 VS 2024 VS 2023
3.4 Global Orally Disintegrating Drug Market Concentration Ratio
3.4.1 Global Orally Disintegrating Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orally Disintegrating Drug Revenue in 2024
3.5 Global Key Players of Orally Disintegrating Drug Head office and Area Served
3.6 Global Key Players of Orally Disintegrating Drug, Product and Application
3.7 Global Key Players of Orally Disintegrating Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Orally Disintegrating Drug Breakdown Data by Type
4.1 Global Orally Disintegrating Drug Historic Market Size by Type (2018-2023)
4.2 Global Orally Disintegrating Drug Forecasted Market Size by Type (2024-2034)
5 Orally Disintegrating Drug Breakdown Data by Application
5.1 Global Orally Disintegrating Drug Historic Market Size by Application (2018-2023)
5.2 Global Orally Disintegrating Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Orally Disintegrating Drug Market Size (2018-2034)
6.2 North America Orally Disintegrating Drug Market Size by Type
6.2.1 North America Orally Disintegrating Drug Market Size by Type (2018-2023)
6.2.2 North America Orally Disintegrating Drug Market Size by Type (2024-2034)
6.2.3 North America Orally Disintegrating Drug Market Share by Type (2018-2034)
6.3 North America Orally Disintegrating Drug Market Size by Application
6.3.1 North America Orally Disintegrating Drug Market Size by Application (2018-2023)
6.3.2 North America Orally Disintegrating Drug Market Size by Application (2024-2034)
6.3.3 North America Orally Disintegrating Drug Market Share by Application (2018-2034)
6.4 North America Orally Disintegrating Drug Market Size by Country
6.4.1 North America Orally Disintegrating Drug Market Size by Country: 2018 VS 2024 VS 2034
6.4.2 North America Orally Disintegrating Drug Market Size by Country (2018-2023)
6.4.3 North America Orally Disintegrating Drug Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Orally Disintegrating Drug Market Size (2018-2034)
7.2 Europe Orally Disintegrating Drug Market Size by Type
7.2.1 Europe Orally Disintegrating Drug Market Size by Type (2018-2023)
7.2.2 Europe Orally Disintegrating Drug Market Size by Type (2024-2034)
7.2.3 Europe Orally Disintegrating Drug Market Share by Type (2018-2034)
7.3 Europe Orally Disintegrating Drug Market Size by Application
7.3.1 Europe Orally Disintegrating Drug Market Size by Application (2018-2023)
7.3.2 Europe Orally Disintegrating Drug Market Size by Application (2024-2034)
7.3.3 Europe Orally Disintegrating Drug Market Share by Application (2018-2034)
7.4 Europe Orally Disintegrating Drug Market Size by Country
7.4.1 Europe Orally Disintegrating Drug Market Size by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Orally Disintegrating Drug Market Size by Country (2018-2023)
7.4.3 Europe Orally Disintegrating Drug Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Orally Disintegrating Drug Market Size (2018-2034)
8.2 China Orally Disintegrating Drug Market Size by Type
8.2.1 China Orally Disintegrating Drug Market Size by Type (2018-2023)
8.2.2 China Orally Disintegrating Drug Market Size by Type (2024-2034)
8.2.3 China Orally Disintegrating Drug Market Share by Type (2018-2034)
8.3 China Orally Disintegrating Drug Market Size by Application
8.3.1 China Orally Disintegrating Drug Market Size by Application (2018-2023)
8.3.2 China Orally Disintegrating Drug Market Size by Application (2024-2034)
8.3.3 China Orally Disintegrating Drug Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Orally Disintegrating Drug Market Size (2018-2034)
9.2 Asia Orally Disintegrating Drug Market Size by Type
9.2.1 Asia Orally Disintegrating Drug Market Size by Type (2018-2023)
9.2.2 Asia Orally Disintegrating Drug Market Size by Type (2024-2034)
9.2.3 Asia Orally Disintegrating Drug Market Share by Type (2018-2034)
9.3 Asia Orally Disintegrating Drug Market Size by Application
9.3.1 Asia Orally Disintegrating Drug Market Size by Application (2018-2023)
9.3.2 Asia Orally Disintegrating Drug Market Size by Application (2024-2034)
9.3.3 Asia Orally Disintegrating Drug Market Share by Application (2018-2034)
9.4 Asia Orally Disintegrating Drug Market Size by Region
9.4.1 Asia Orally Disintegrating Drug Market Size by Region: 2018 VS 2024 VS 2034
9.4.2 Asia Orally Disintegrating Drug Market Size by Region (2018-2023)
9.4.3 Asia Orally Disintegrating Drug Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Orally Disintegrating Drug Introduction
11.1.4 Johnson and Johnson Revenue in Orally Disintegrating Drug Business (2018-2023)
11.1.5 Johnson and Johnson Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Orally Disintegrating Drug Introduction
11.2.4 GSK Revenue in Orally Disintegrating Drug Business (2018-2023)
11.2.5 GSK Recent Developments
11.3 Otsuka
11.3.1 Otsuka Company Details
11.3.2 Otsuka Business Overview
11.3.3 Otsuka Orally Disintegrating Drug Introduction
11.3.4 Otsuka Revenue in Orally Disintegrating Drug Business (2018-2023)
11.3.5 Otsuka Recent Developments
11.4 Vartris
11.4.1 Vartris Company Details
11.4.2 Vartris Business Overview
11.4.3 Vartris Orally Disintegrating Drug Introduction
11.4.4 Vartris Revenue in Orally Disintegrating Drug Business (2018-2023)
11.4.5 Vartris Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Orally Disintegrating Drug Introduction
11.5.4 Teva Revenue in Orally Disintegrating Drug Business (2018-2023)
11.5.5 Teva Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Orally Disintegrating Drug Introduction
11.6.4 Pfizer Revenue in Orally Disintegrating Drug Business (2018-2023)
11.6.5 Pfizer Recent Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Orally Disintegrating Drug Introduction
11.7.4 Eli Lilly and Company Revenue in Orally Disintegrating Drug Business (2018-2023)
11.7.5 Eli Lilly and Company Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Orally Disintegrating Drug Introduction
11.8.4 Merck Revenue in Orally Disintegrating Drug Business (2018-2023)
11.8.5 Merck Recent Developments
11.9 Eisai
11.9.1 Eisai Company Details
11.9.2 Eisai Business Overview
11.9.3 Eisai Orally Disintegrating Drug Introduction
11.9.4 Eisai Revenue in Orally Disintegrating Drug Business (2018-2023)
11.9.5 Eisai Recent Developments
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Orally Disintegrating Drug Introduction
11.10.4 AstraZeneca Revenue in Orally Disintegrating Drug Business (2018-2023)
11.10.5 AstraZeneca Recent Developments
11.11 Bristol-Myers Squibb
11.11.1 Bristol-Myers Squibb Company Details
11.11.2 Bristol-Myers Squibb Business Overview
11.11.3 Bristol-Myers Squibb Orally Disintegrating Drug Introduction
11.11.4 Bristol-Myers Squibb Revenue in Orally Disintegrating Drug Business (2018-2023)
11.11.5 Bristol-Myers Squibb Recent Developments
11.12 Conquer
11.12.1 Conquer Company Details
11.12.2 Conquer Business Overview
11.12.3 Conquer Orally Disintegrating Drug Introduction
11.12.4 Conquer Revenue in Orally Disintegrating Drug Business (2018-2023)
11.12.5 Conquer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Orally Disintegrating Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of Anti-Psychotics Drug
Table 3. Key Players of Anti-Epileptics Drug
Table 4. Key Players of Other
Table 5. Global Orally Disintegrating Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 6. Global Orally Disintegrating Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Orally Disintegrating Drug Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Orally Disintegrating Drug Market Share by Region (2018-2023)
Table 9. Global Orally Disintegrating Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Orally Disintegrating Drug Market Share by Region (2024-2034)
Table 11. Orally Disintegrating Drug Market Trends
Table 12. Orally Disintegrating Drug Market Drivers
Table 13. Orally Disintegrating Drug Market Challenges
Table 14. Orally Disintegrating Drug Market Restraints
Table 15. Global Orally Disintegrating Drug Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Orally Disintegrating Drug Revenue Share by Players (2018-2023)
Table 17. Global Top Orally Disintegrating Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Drug as of 2024)
Table 18. Global Orally Disintegrating Drug Industry Ranking 2021 VS 2024 VS 2023
Table 19. Global 5 Largest Players Market Share by Orally Disintegrating Drug Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Orally Disintegrating Drug, Headquarters and Area Served
Table 21. Global Key Players of Orally Disintegrating Drug, Product and Application
Table 22. Global Key Players of Orally Disintegrating Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Orally Disintegrating Drug Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Orally Disintegrating Drug Revenue Market Share by Type (2018-2023)
Table 26. Global Orally Disintegrating Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Orally Disintegrating Drug Revenue Market Share by Type (2024-2034)
Table 28. Global Orally Disintegrating Drug Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Orally Disintegrating Drug Revenue Share by Application (2018-2023)
Table 30. Global Orally Disintegrating Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Orally Disintegrating Drug Revenue Share by Application (2024-2034)
Table 32. North America Orally Disintegrating Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Orally Disintegrating Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. North America Orally Disintegrating Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Orally Disintegrating Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. North America Orally Disintegrating Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. North America Orally Disintegrating Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Orally Disintegrating Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. Europe Orally Disintegrating Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Orally Disintegrating Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. Europe Orally Disintegrating Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Orally Disintegrating Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. Europe Orally Disintegrating Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Europe Orally Disintegrating Drug Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Orally Disintegrating Drug Market Size by Country (2024-2034) & (US$ Million)
Table 46. China Orally Disintegrating Drug Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Orally Disintegrating Drug Market Size by Type (2024-2034) & (US$ Million)
Table 48. China Orally Disintegrating Drug Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Orally Disintegrating Drug Market Size by Application (2024-2034) & (US$ Million)
Table 50. Asia Orally Disintegrating Drug Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Orally Disintegrating Drug Market Size by Type (2024-2034) & (US$ Million)
Table 52. Asia Orally Disintegrating Drug Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Orally Disintegrating Drug Market Size by Application (2024-2034) & (US$ Million)
Table 54. Asia Orally Disintegrating Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 55. Asia Orally Disintegrating Drug Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Orally Disintegrating Drug Market Size by Region (2024-2034) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Type (2024-2034) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Application (2024-2034) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Orally Disintegrating Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 62. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size by Country (2024-2034) & (US$ Million)
Table 64. Johnson and Johnson Company Details
Table 65. Johnson and Johnson Business Overview
Table 66. Johnson and Johnson Orally Disintegrating Drug Product
Table 67. Johnson and Johnson Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 68. Johnson and Johnson Recent Developments
Table 69. GSK Company Details
Table 70. GSK Business Overview
Table 71. GSK Orally Disintegrating Drug Product
Table 72. GSK Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 73. GSK Recent Developments
Table 74. Otsuka Company Details
Table 75. Otsuka Business Overview
Table 76. Otsuka Orally Disintegrating Drug Product
Table 77. Otsuka Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 78. Otsuka Recent Developments
Table 79. Vartris Company Details
Table 80. Vartris Business Overview
Table 81. Vartris Orally Disintegrating Drug Product
Table 82. Vartris Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 83. Vartris Recent Developments
Table 84. Teva Company Details
Table 85. Teva Business Overview
Table 86. Teva Orally Disintegrating Drug Product
Table 87. Teva Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 88. Teva Recent Developments
Table 89. Pfizer Company Details
Table 90. Pfizer Business Overview
Table 91. Pfizer Orally Disintegrating Drug Product
Table 92. Pfizer Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 93. Pfizer Recent Developments
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Orally Disintegrating Drug Product
Table 97. Eli Lilly and Company Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 98. Eli Lilly and Company Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Orally Disintegrating Drug Product
Table 102. Merck Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 103. Merck Recent Developments
Table 104. Eisai Company Details
Table 105. Eisai Business Overview
Table 106. Eisai Orally Disintegrating Drug Product
Table 107. Eisai Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 108. Eisai Recent Developments
Table 109. AstraZeneca Company Details
Table 110. AstraZeneca Business Overview
Table 111. AstraZeneca Orally Disintegrating Drug Product
Table 112. AstraZeneca Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 113. AstraZeneca Recent Developments
Table 114. Bristol-Myers Squibb Company Details
Table 115. Bristol-Myers Squibb Business Overview
Table 116. Bristol-Myers Squibb Orally Disintegrating Drug Product
Table 117. Bristol-Myers Squibb Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 118. Bristol-Myers Squibb Recent Developments
Table 119. Conquer Company Details
Table 120. Conquer Business Overview
Table 121. Conquer Orally Disintegrating Drug Product
Table 122. Conquer Revenue in Orally Disintegrating Drug Business (2018-2023) & (US$ Million)
Table 123. Conquer Recent Developments
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Orally Disintegrating Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 2. Global Orally Disintegrating Drug Market Share by Type: 2024 VS 2034
Figure 3. Anti-Psychotics Drug Features
Figure 4. Anti-Epileptics Drug Features
Figure 5. Other Features
Figure 6. Global Orally Disintegrating Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Orally Disintegrating Drug Market Share by Application: 2024 VS 2034
Figure 8. CNS Diseases Case Studies
Figure 9. Gastrointestinal Diseases Case Studies
Figure 10. CVS Diseases Case Studies
Figure 11. Other Case Studies
Figure 12. Orally Disintegrating Drug Report Years Considered
Figure 13. Global Orally Disintegrating Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Orally Disintegrating Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Orally Disintegrating Drug Market Share by Region: 2024 VS 2034
Figure 16. Global Orally Disintegrating Drug Market Share by Players in 2024
Figure 17. Global Top Orally Disintegrating Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Drug as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Orally Disintegrating Drug Revenue in 2024
Figure 19. North America Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Orally Disintegrating Drug Market Share by Type (2018-2034)
Figure 21. North America Orally Disintegrating Drug Market Share by Application (2018-2034)
Figure 22. North America Orally Disintegrating Drug Market Share by Country (2018-2034)
Figure 23. United States Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Orally Disintegrating Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 26. Europe Orally Disintegrating Drug Market Share by Type (2018-2034)
Figure 27. Europe Orally Disintegrating Drug Market Share by Application (2018-2034)
Figure 28. Europe Orally Disintegrating Drug Market Share by Country (2018-2034)
Figure 29. Germany Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. France Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. U.K. Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Italy Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Russia Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Nordic Countries Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. China Orally Disintegrating Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 36. China Orally Disintegrating Drug Market Share by Type (2018-2034)
Figure 37. China Orally Disintegrating Drug Market Share by Application (2018-2034)
Figure 38. Asia Orally Disintegrating Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 39. Asia Orally Disintegrating Drug Market Share by Type (2018-2034)
Figure 40. Asia Orally Disintegrating Drug Market Share by Application (2018-2034)
Figure 41. Asia Orally Disintegrating Drug Market Share by Region (2018-2034)
Figure 42. Japan Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. South Korea Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. China Taiwan Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Southeast Asia Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. India Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Australia Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Size YoY (2018-2034) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Share by Type (2018-2034)
Figure 50. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Share by Application (2018-2034)
Figure 51. Middle East, Africa, and Latin America Orally Disintegrating Drug Market Share by Country (2018-2034)
Figure 52. Brazil Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Mexico Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Turkey Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Israel Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. GCC Countries Orally Disintegrating Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Johnson and Johnson Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 59. GSK Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 60. Otsuka Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 61. Vartris Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 62. Teva Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 63. Pfizer Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 65. Merck Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 66. Eisai Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 67. AstraZeneca Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 69. Conquer Revenue Growth Rate in Orally Disintegrating Drug Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries